22 March 2018Hard numbers vs projected numbers: Valuing Emerald Therapeutics (EMH.V) vs…Equity Guru This article is part of an ongoing series that uses company documents to break apart and visualize data relating to the Canadian cannabis producer market. We’ve noted a few…